Likewise, Maniam et al. demonstrated that combined chemotherapeutic treatments enhanced Bax expression while reducing Bcl-2 in pancreatic tumor models, thereby shifting the Bax/Bcl-2 ratio toward apoptosis [27]. Here, BCL2 is linked to pancreatic neoplasm.